1. Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States.

    Annals of Internal Medicine 162(8):533 (2015) PMID 25894023

    Evidence to guide primary prevention in adults aged 75 years or older is limited. To project the population impact and cost-effectiveness of statin therapy in adults aged 75 years or older. Forecasting study using the Cardiovascular Disease Policy Model, a Markov model. Trial, cohort, and nation...
  2. Cost-effectiveness of hypertension therapy according to 2014 guidelines.

    New England Journal of Medicine 372(5):447 (2015) PMID 25629742 PMCID PMC4403858

    On the basis of the 2014 guidelines for hypertension therapy in the United States, many eligible adults remain untreated. We projected the cost-effectiveness of treating hypertension in U.S. adults according to the 2014 guidelines. We used the Cardiovascular Disease Policy Model to simulate drug...
  3. Cost-effectiveness of hypertension therapy according to 2014 guidelines.

    New England Journal of Medicine 372(5):447 (2015) PMID 25629742

    On the basis of the 2014 guidelines for hypertension therapy in the United States, many eligible adults remain untreated. We projected the cost-effectiveness of treating hypertension in U.S. adults according to the 2014 guidelines. We used the Cardiovascular Disease Policy Model to simulate drug...
  4. Cost-effectiveness of hypertension therapy according to 2014 guidelines.

    New England Journal of Medicine 372(5):447 (2015) PMID 25629742 PMCID PMC4403858

    On the basis of the 2014 guidelines for hypertension therapy in the United States, many eligible adults remain untreated. We projected the cost-effectiveness of treating hypertension in U.S. adults according to the 2014 guidelines. We used the Cardiovascular Disease Policy Model to simulate drug...
  5. Cost-effectiveness of hypertension therapy according to 2014 guidelines.

    New England Journal of Medicine 372(5):447 (2015) PMID 25629742

    On the basis of the 2014 guidelines for hypertension therapy in the United States, many eligible adults remain untreated. We projected the cost-effectiveness of treating hypertension in U.S. adults according to the 2014 guidelines. We used the Cardiovascular Disease Policy Model to simulate drug...
  6. Cost-effectiveness of hypertension therapy according to 2014 guidelines.

    New England Journal of Medicine 372(5):447 (2015) PMID 25629742

    On the basis of the 2014 guidelines for hypertension therapy in the United States, many eligible adults remain untreated. We projected the cost-effectiveness of treating hypertension in U.S. adults according to the 2014 guidelines. We used the Cardiovascular Disease Policy Model to simulate drug...
  7. Cost-Effectiveness of Hypertension Therapy According to 2014 Guidelines

    New England Journal of Medicine 372(5):447 (2015)

    Background On the basis of the 2014 guidelines for hypertension therapy in the United States, many eligible adults remain untreated. We projected the cost-effectiveness of treating hypertension in U.S. adults according to the 2014 guidelines.
  8. Cost-effectiveness of hypertension therapy according to 2014 guidelines.

    New England Journal of Medicine 372(5):447 (2015) PMID 25629742 PMCID PMC4403858

    On the basis of the 2014 guidelines for hypertension therapy in the United States, many eligible adults remain untreated. We projected the cost-effectiveness of treating hypertension in U.S. adults according to the 2014 guidelines. We used the Cardiovascular Disease Policy Model to simulate drug...
  9. 40 years of training physician-scientists: a journey from clinical pearls to evidence-based practice and policies.

    Annals of Internal Medicine 161(10 Suppl):S2 (2014) PMID 25402399

  10. 40 years of training physician-scientists: a journey from clinical pearls to evidence-based practice and policies.

    Annals of Internal Medicine 161(10 Suppl):S2 (2014) PMID 25402399

  11. Cost-effectiveness of optimal use of acute myocardial infarction treatments and impact on coronary heart disease mortality in China.

    Circulation: Cardiovascular Quality and Outcomes 7(1):78 (2014) PMID 24425706 PMCID PMC4191653

    The cost-effectiveness of the optimal use of hospital-based acute myocardial infarction (AMI) treatments and their potential impact on coronary heart disease (CHD) mortality in China is not well known. The effectiveness and costs of optimal use of hospital-based AMI treatments were estimated by ...
  12. An intellectual agenda for hospitalists: lessons from bloodletting.

    Journal Of Hospital Medicine 8(7):418 (2013) PMID 23401423

  13. An intellectual agenda for hospitalists: lessons from bloodletting.

    Journal Of Hospital Medicine 8(7):418 (2013) PMID 23401423

  14. How provocative is provocative testing?: comment on "Yield of routine provocative cardiac testing among patients in an emergency department-based chest pain unit.

    JAMA Internal Medicine 173(12):1134 (2013) PMID 23689511

  15. [The cost-utility ratio of reducing salt intake and its impact on the incidence of cardiovascular disease in Argentina].

    Revista Panamericana de Salud Publica/Pan Ameri... 32(4):274 (2012) PMID 23299288

    Estimate the cost-utility ratio of an intervention to reduce dietary salt intake in people over the age of 35 in Argentina. The intervention consisted of reducing salt content in food by 5% to 25%. A simulation model was used to measure the impact of policies on heart disease in order to predict...
    PDF not found
  16. Projected impact of urbanization on cardiovascular disease in China.

    International Journal of Public Health 57(5):849 (2012) PMID 22918518 PMCID PMC3465962

    The Coronary Heart Disease (CHD) Policy Model-China, a national scale cardiovascular disease computer simulation model, was used to project future impact of urbanization. Populations and cardiovascular disease incidence rates were stratified into four submodels: North-Urban, South-Urban, North-R...
  17. [The cost-utility ratio of reducing salt intake and its impact on the incidence of cardiovascular disease in Argentina].

    Revista Panamericana de Salud Publica/Pan Ameri... 32(4):274 (2012) PMID 23299288

    Estimate the cost-utility ratio of an intervention to reduce dietary salt intake in people over the age of 35 in Argentina. The intervention consisted of reducing salt content in food by 5% to 25%. A simulation model was used to measure the impact of policies on heart disease in order to predict...
    PDF not found
  18. Letter by Lee and Goldman regarding article, "Development and validation of a risk calculator for prediction of cardiac risk after surgery".

    Circulation 125(7):e385; author reply e386 (2012) PMID 22354985

  19. Using stress testing to guide primary prevention of coronary heart disease among intermediate-risk patients: a cost-effectiveness analysis.

    Circulation 125(2):260 (2012) PMID 22144567 PMCID PMC3265963

    Noninvasive stress testing might guide the use of aspirin and statins for primary prevention of coronary heart disease, but it is unclear if such a strategy would be cost effective. We compared the status quo, in which the current national use of aspirin and statins was simulated, with 3 other s...
  20. A penny-per-ounce tax on sugar-sweetened beverages would cut health and cost burdens of diabetes.

    Health Affairs 31(1):199 (2012) PMID 22232111

    Sugar-sweetened beverages are a major contributor to the US obesity and diabetes epidemics. Using the Coronary Heart Disease Policy Model, we examined the potential impact on health and health spending of a nationwide penny-per-ounce excise tax on these beverages. We found that the tax would red...